Non-alcoholic Fatty Liver Disease: Gastroenterology
Clinical Gastroenterology Journal is a peer reviewed, open access journal considering submissions on topics covering on all aspects of digestive system, gastrointestinal diseases, liver, bilary tract, pancreas, diseases of related organs Ulcer medicine, Colitis, Diverticulitis and associated disorders and their treatment.
The Journal aims to provide a platform for the exchange of scientific information addressing clinical research and practice of Gastroenterology and Hepatology.
Non-alcoholic fatty liver disease (NAFLD):
It is a very common disorder and refers to a group of conditions where there is accumulation of excess fat in the liver of people who drink little or no alcohol. The most common form of NAFLD is a non serious condition called fatty liver. In fatty liver, fat accumulates in the liver cells.
NAFLD is increasingly common around the world, especially in Western nations. In the United States, it is the most common form of chronic liver disease, affecting about one-quarter of the population.
NAFLD usually causes no signs and symptoms. When it does, they may include:
• Pain or discomfort in the upper right abdomen
Possible signs and symptoms:
• Abdominal swelling (ascites)
• Enlarged blood vessels just beneath the skin's surface
• Enlarged spleen
• Red palms
• Yellowing of the skin and eyes (jaundice)
• Overweight or obesity
• Insulin resistance, in which your cells don't take up sugar in response to the hormone insulin
• High blood sugar (hyperglycemia), indicating prediabetes or type 2 diabetes
• High levels of fats, particularly triglycerides, in the blood
• High cholesterol
• High levels of triglycerides in the blood
• Metabolic syndrome
• Obesity, particularly when fat is concentrated in the abdomen
• Polycystic ovary syndrome
• Sleep apnea
• Type 2 diabetes
• Underactive thyroid (hypothyroidism)
The main complication of NAFLD and NASH is cirrhosis, which is late stage scarring in the liver. Cirrhosis occurs in response to liver injury, such as the inflammation in NASH.
• Choose a healthy diet. Choose a healthy plant-based diet that's rich in fruits, vegetables, whole grains and healthy fats.
• Maintain a healthy weight. If you are overweight or obese, reduce the number of calories you eat each day and get more exercise.If you have a healthy weight, work to maintain it by choosing a healthy diet and exercising.
• Exercise. Exercise most days of the week.
During this year we look forward to taking some initiatives that would encourage and reward our prospective audience which include clinicians, research scientists, decision-makers and a range of professionals in the Clinical Gastroenterology.
It gives us great pleasure to invite Prospective academicians and scientists and encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges. The Journal accepts original manuscripts in the form of Research articles, Review articles, Clinical reviews, Commentaries, Case reports, Perspectives and Short communications encompassing all aspects of Clinical Gastroenterology and Hepatology for publication in open access platform.
All the manuscript published by Clinical Gastroenterology Journal are available freely online immediately after publication without any subscription charges or registration.
If your manuscript is ready you can submit it directly online: https://www.scholarscentral.org/submission/clinical-gastreoenterology-journal.html or as an attachment to this E-mail: firstname.lastname@example.org
How we work:
• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.
Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Follow us on twitter for latest updates regarding Gastroenterology at : https://twitter.com/Gastroenterol
Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.
Clinical Gastroenterology Journal